Crosstalk between cannabinoid receptor 2 and lysophosphatidic acid receptor 5.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
23 07 2023
Historique:
received: 27 04 2023
accepted: 29 04 2023
medline: 1 6 2023
pubmed: 16 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Cannabinoid receptor 2 (CB

Identifiants

pubmed: 37187093
pii: S0006-291X(23)00552-1
doi: 10.1016/j.bbrc.2023.04.115
pii:
doi:

Substances chimiques

Lysophospholipids 0
Receptors, Cannabinoid 0
Receptors, Lysophosphatidic Acid 0
LPAR5 protein, human 0
CNR2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-161

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interest.

Auteurs

Eunju Song (E)

Department of Life Science, Kyonggi University, Suwon, 16227, Republic of Korea.

Sungho Ghil (S)

Department of Life Science, Kyonggi University, Suwon, 16227, Republic of Korea. Electronic address: shghil@kyonggi.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH